14.02.2013
- Swiss specialty chemicals firm Clariant said on Thursday it expected its slimmed-down business to deliver higher margins and net income, with emerging markets providing most of the...
14.02.2013
- Swiss group Actelion has raised its dividend 25% as it awaits a U.S. regulatory decision on a new heart and lung drug it hopes will cut its dependency on current mainstay Tracleer...
14.02.2013
- President Barack Obama's decision to spotlight drug rebates as a way to save money on Medicare is likely to be opposed by the pharmaceutical industry, which could potentially lose...
13.02.2013
- Total plans to raise its exploration budget in 2013 under an investment policy that takes advantage of high oil prices and financing from large-scale asset sales. The world's fifth...
13.02.2013
- An unusually severe cold and flu season in the United States helped drive full-year profits higher at Britain's Reckitt Benckiser, maker of Strepsils throat lozenges and Mucinex...
13.02.2013
- Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drugs firms to...
12.02.2013
- Booming shale gas production is reshaping the energy outlook in the United States and Washington must re-examine how it regulates natural gas development and exports, lawmakers...
12.02.2013
- Novozymes Biopharma today announced a collaborative research agreement with Rhode Island-based biotech company EpiVax, to help further the development of a treatment for autoimmune...
12.02.2013
- Brenntag, the global chemical distributor, is upgrading its Brenntag Pacific site in Dickinson, North Dakota in order to satisfy customers' demand in the high growth North Dakota...
12.02.2013
- Brazil's big sugarcane mills have begun to invest in ethanol production again, after licking their wounds from years of slim margins, as an expanding crop and favorable government...
